Principal Securities’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Principal Securities’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-997	Closed	-$200K	–	1552
2026 Q1	$200K	Buy	+997	New	+$206K	﹤0.01%	1386
2025 Q4	–	Sell	-864	Closed	-$155K	–	2053
2025 Q3	$155K	Buy	864 +25	+3%	+$4.26K	﹤0.01%	1403
2025 Q2	$135K	Buy	839 +109	+15%	+$17.4K	﹤0.01%	1402
2025 Q1	$121K	Hold	730	–	–	﹤0.01%	1345
2024 Q4	$121K	Buy	730 +106	+17%	+$18.1K	﹤0.01%	1345
2024 Q3	$107K	Buy	624 +423	+210%	+$70K	﹤0.01%	1367
2024 Q2	$31K	Hold	201	–	–	﹤0.01%	1843
2024 Q1	$30.9K	Hold	201	–	–	﹤0.01%	1785
2023 Q4	$31.8K	Buy	+201	New	+$28.9K	﹤0.01%	1687

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Principal Securities's FBT Position: Q2 2026 in Review

Principal Securities sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2026, closing a stake of 997 shares — an estimated $200K sold.

Principal Securities first reported a position in FBT in Q4 2023 and held it in 9 quarters. The position peaked at $200K in Q1 2026. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

Principal Securities reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2026 after selling out during the quarter.
Principal Securities sold 997 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $200K.
Principal Securities first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2023 and held it in 9 quarters.
Principal Securities's First Trust NYSE Arca Biotechnology Index Fund position peaked at $200K in Q1 2026.
339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Principal Securities's 13F filing for Q2 2026, filed 4 Aug 2026.